Table 5. Top 10 Pathway Maps Enriched with Clorgyline’s DEGs.

No.	pathway map	union p-value	DEG p-value	key hubs p-value	direction
1	ligand-independent activation of androgen receptor in prostate cancer	4.91 × 10–10	5.68 × 10–04	4.34 × 10–07	NA
2	role of microRNAs in cell proliferation in colorectal cancer	1.37 × 10–08	3.66 × 10–02	2.06 × 10–07	NA
3	development_androgen receptor in reproductive system development	4.67 × 10–08	7.75 × 10–03	3.02 × 10–06	–
4	WNT signaling in the progression of lung cancer	5.89 × 10–08	8.11 × 10–03	3.59 × 10–06	NA
5	DNA damage_double-strand break repair via homologous recombination	6.40 × 10–08	2.37 × 10–04	1.30 × 10–05	+
6	TGF-beta signaling via kinase cascades in breast cancer	1.50 × 10–07	2.26 × 10–02	5.85 × 10–07	NA
7	regulation of GSK3 beta in bipolar disorder	1.74 × 10–07	1.14 × 10–02	8.40 × 10–06	NA
8	signal transduction_S1P1 receptor signaling	3.27 × 10–07	2.71 × 10–02	5.72 × 10–06	NA
9	DNA damage_ATM activation by DNA damage	3.69 × 10–07	7.48 × 10–04	1.24 × 10–04	NA
10	role of inhibition of WNT signaling in the progression of lung cancer	8.35 × 10–07	4.13 × 10–02	1.24 × 10–05	NA